Viewing Study NCT03596294


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-25 @ 11:38 PM
Study NCT ID: NCT03596294
Status: COMPLETED
Last Update Posted: 2018-10-23
First Post: 2018-07-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module